collaborators

1 paper

stat.ME2025

A Bayesian model-free dose-finding approach in Phase II clinical trials with the flexibility of historical borrowing

Linxi Han, Qiqi Deng, Feng Yu +1

Accurate dose selection in Phase II trials is critical to the success of subsequent Phase III trials, but suboptimal choices remain a leading cause of trial failure and regulatory…